Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Profit After Tax (2023 - 2025)

Rallybio's Profit After Tax history spans 3 years, with the latest figure at $16.0 million for Q3 2025.

  • For Q3 2025, Profit After Tax rose 239.68% year-over-year to $16.0 million; the TTM value through Sep 2025 reached -$14.2 million, up 78.85%, while the annual FY2024 figure was -$57.8 million, 22.55% up from the prior year.
  • Profit After Tax for Q3 2025 was $16.0 million at Rallybio, up from -$9.7 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $16.0 million in Q3 2025 and bottomed at -$20.3 million in Q4 2023.
  • The 3-year median for Profit After Tax is -$16.2 million (2024), against an average of -$12.3 million.
  • The largest annual shift saw Profit After Tax dropped 9.88% in 2024 before it soared 239.68% in 2025.
  • A 3-year view of Profit After Tax shows it stood at -$20.3 million in 2023, then soared by 45.54% to -$11.0 million in 2024, then surged by 245.02% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Profit After Tax are $16.0 million (Q3 2025), -$9.7 million (Q2 2025), and -$9.4 million (Q1 2025).